Table: Daito - 9-MTH group results

Daito Pharmaceutical

14/04/2020 07:00

Apr 14 (Reuters)- 
             Daito Pharamaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended       Year to 
                  Feb 29, 2020        Feb 28, 2019     May 31, 2020 
                     LATEST             YEAR-AGO          LATEST    
                     RESULTS             RESULTS         FORECAST   
  Sales               34.37               30.40            43.50    
                   (+13.1 pct)         (+2.6 pct)       (+5.7 pct)  
  Operating            4.58                3.67             4.70    
                   (+25.1 pct)         (+15.1 pct)      (+3.4 pct)  
  Recurring            4.64                3.75             4.75    
                   (+23.7 pct)         (+15.6 pct)      (+2.3 pct)  
  Net                  3.24                2.55             3.30    
                   (+27.1 pct)         (+10.9 pct)      (-6.1 pct)  
  EPS              256.48 yen          203.81 yen       263.71 yen  
  EPS Diluted      254.98 yen                                       
  Ann Div                               38.00 yen        46.00 yen  
  -Q2 div           20.00 yen           18.00 yen                   
  -Q4 div                               20.00 yen        26.00 yen  
  
  NOTE - Daito Pharamaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4577.T